Log in

8279 Syngen Biotech Co., Ltd. TPEX · Taiwan

Syngen Biotech Co. (8279) news

Syngen Biotech Co., Ltd. is a public biotech or pharmaceutical company listed on TPEX under the ticker 8279, recorded under Taiwan. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Syngen Biotech Co. news

We have not published a story on Syngen Biotech Co. yet. When there is news, it will appear here.

Questions about Syngen Biotech Co.

What is the ticker symbol of Syngen Biotech Co.?

Syngen Biotech Co., Ltd. trades under the ticker 8279 on TPEX.

Where is Syngen Biotech Co. listed?

Syngen Biotech Co., Ltd. is listed on TPEX.

Which country or territory is Syngen Biotech Co. listed under?

Our directory records Syngen Biotech Co., Ltd. under Taiwan.

What does Syngen Biotech Co. do?

Our directory classifies Syngen Biotech Co., Ltd. as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of Syngen Biotech Co.?

The ISIN recorded for Syngen Biotech Co., Ltd. is TW0008279001.

Does aibio.space cover Syngen Biotech Co.?

aibio.space lists Syngen Biotech Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Syngen Biotech Co.?

Companies in our directory listed in the same country and business area as Syngen Biotech Co.: Annji Pharmaceutical Co., Mycenax Biotech, Maxigen Biotech, TFBS Bioscience, TLC BioSciences, Pharmasaga Co..

Investor discussion: Syngen Biotech Co.

Members talk about Syngen Biotech Co. (8279). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open TPEX:8279 on TradingView.

Listing details

Syngen Biotech Co., Ltd. is a public biotech or pharmaceutical company listed on TPEX under the ticker 8279, recorded under Taiwan. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Syngen Biotech Co., Ltd.
Ticker
8279
Listing
TPEX
Country or territory
Taiwan
Business scope
Biotechnology
ISIN
TW0008279001
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.